.., .. . .: , 2001. - 640 .

.. D. , .

1989. - .38-51.

.., ..

. .: .

1990. - .140-143.

.., ..; ..; ..; - ..; .. D. . . 1995. 6. .55-57.

. . ... .: . 1974. 496 .

. ..Ѯ. 2000-2008. http://www.rlsnet.ru/.

. ., . .. . . 2003. 02 (http://www.lvrach. ru/doctore/2003/02/4530068/).

.. . . .. . 2008. 87. 02.

.. . . 2003. 4, . 59. .79-80.

..; ..; ..; ..; .. - 3 (). ., . .-. . . 1996. - .171-172.

, , , 2008.

, . . . , 1989. - .621-631.

.., .., .. D3 , , 2008, N1.

.. . . . - . - .: ̻. - , 2- ., ., 1999. - .135, 139-145.

Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA. Antitumor Effects of Two Less-Calcemic Vitamin D Analogs (Paricalcitol and QW-1624F(2)- 2) in Squamous Cell Carcinoma Cells. Oncology. 2007 Jan 18;70(6):483-492. (PubMed abstract).

Alpert PT, Shaikh U. The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems. Biol Res Nurs. 2007 Oct;9(2):117-29.

Avila E, Diaz L, Barrera D, Arranz C, Halhali A, Larrea F.Metabolism of vitamin D in the human choriocarcinoma cell line JEG-3.J. Steroid. Biochem. Mol. Biol. 2007 Jan 23. (PubMed abstract).

Barley NF, Prathalingam SR, Zhi P, Legon S, Howard A, Walters JR. Factors involved in the duodenal expression of the human calbindin-D9k gene. Biochem J. 1999;341 (Pt 3:491 -500.

BlackmoreKM, LesoskyM, BarnettH, RaboudJM, ViethR, KnightJA.Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor- defined breast cancer. Am J Epidemiol. 2008 Oct 15;168(8):915-24.

Block LH, Buhler FR. Atherosclerosis, cell motility, calcium, and calciumchannel blockers.

J Cardiovasc Pharmacol. 1992;19 Suppl 2:S 1 -S3.

Brevetti G, Colao A, Schiano V, Pivonello R, Laurenzano E, Di Somma C, Lombardi G, Chiariello M. IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb. Clin Endocrinol (Oxf). 2008;69(6):894-900 Epub 2008 A.

Brown, J., Bianco, J.I., McGrath J.J., andEyles, D.W. 2003. NeurosciLett., 343, 139-143.

CaiF, Shen P, WalkerGD, Reynolds C, Yuan Y, ReynoldsEC.Remineralization of enamel subsurface lesions by chewing gum with added calcium. J Dent. 2009 Oct;37(10):763-8.

Carlberg C, Seuter S. A genomic perspective on vitamin D signaling. Anticancer Res. 2009;29(9):3485-3493.

Chen S, Tsybouleva N, Ballantyne CM, Gotto AM Jr, Marian AJ. Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenetics. 2004;14(1):61-71.

Christakos S, Dhawan P, Benn B, Porta A, Hediger M, Oh GT, Jeung EB, Zhong Y, Ajibade D, Dhawan K, Joshi S. Vitamin D: molecular mechanism of action. Ann N Y Acad Sci. 2007;1116:340-348.

Cordes T, Diesing D, Becker S, Diedrich K, Reichrath J, Friedrich M. Vitamin D-metabolism in the human breast cancer cell line MCF-7. Anticancer Res. 2006 Jul-Aug;26(4A):2749-53. Davies P.D.O. Vitamin D theory gets another airing. Int. J. Tuberc. and Lung Disease. 1997. 6. - P.584.

Denhardt DT, Noda M, ORegan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001;107(9):1055-1061.

Detrano R, Molloi S. Radiographically detectable calcium and atherosclerosis: the connection and its exploitation. Int J Card Imaging. 1992;8(3):209-215.

Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, Shah PK, Rajavashisth TB. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev. 2004;25(4):629-672.

Du Xueqin; Greenfield Heather; Fraser David R.; Ge Keyou. Osteoporotic X-ray signs and calcium intake among Beijing adolescent girls. Proc. Nutr. Soc. 1997. 3. - P.297.

Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest. 1994;94(4):1597-1604.

Foley RN, Collins AJ, Ishani A, Kalra PA. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2008;156(3):556-563.

Gannage Yared M.H; Tohme A.; Halaby G. Lhypovitaminose D, probleme mondial majeur de sante publique. (Hypovitaminosis D: a major worldwide public health problem). Presse-Med. 2001 Apr 7; 30(13): 653-658.

Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, Newmark H, Holick MF, Garland FC. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):708-11.

Geissler C., Powers H. Human Nutrition, Edinburgh. 2006; 763 P.

Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest. 2003;112(2):147-149.

Hajnoczky G, Csordas G, Das S, Garcia-Perez C, Saotome M, Sinha Roy S, Yi M. Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium. 2006 Nov- Dec;40(5-6):553-60.

Han S, Chiang JY. Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos. 2009;37(3):469-78 Epub 2008 De.

Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PV, Sarma KV, Kumar EG. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr. 2007Apr;85(4):1062-7.

Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, Bartik L, Egan JB, Wu Y, Kubicek JL, Lowmiller CL, Moffet EW, Forster RE, Jurutka PW. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the Fountain of Youth to mediate healthful aging. J Steroid Biochem Mol Biol. 2010;121(1 -2):88-97 Epub 2010 Mar.

Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, Renne T, Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem. 2003;278(15):13333-41 Epub 2003.

Hernandez RH, Armas-Hernandez MJ, Velasco M, Israili ZH, Armas-Padilla MC. Calcium antagonists and atherosclerosis protection in hypertension. Am J Ther. 2003;10(6):409-414.

Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H. Vascular calcification and osteoporosis--from clinical observation towards molecular understanding. Osteoporos Int. 2007;18(3):251 -9 Epub 2006 Dec.

Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, AmeriA, Tannenbaum AD. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008 Mar;93(3):677-81.

Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 Apr;87(4):1080S-6S.

Holick MF. Does vitamin D3 dosing schedule influence treatment efficacy in nursing home residents with vitamin D deficiency? Nat Clin Pract Endocrinol Metab. 2008 Dec;4(12):656-7.

Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017-29.

Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006Aug;116(8):2062-72.

HolickMF.ThevitaminDdeficiencypandemicandconsequencesfornonskeletal health: mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361-8.

Holick MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008 Sep;3(5):1548-54.

Horton K, Marrack J, Price I.The relation of calcium in the saliva to dental caries.Biochem J. 1929;23(5):1075-8.

Hsu JJ, Tintut Y, Demer LL. Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol. 2008;3(5):1542-7 Epub 2008 Ju.

Hyder JA, Allison MA, Barrett-Connor E, Detrano R, Wong ND, Sirlin C, Gapstur SM, Ouyang P, Carr JJ, Criqui MH. Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study. Atherosclerosis. 2010;209(1):283-9 Epub 2009 Sep.

Imamura A, Okumura K, Ogawa Y, Murakami R, Torigoe M, Numaguchi Y, Murohara T. Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese. Clin Chim Acta. 2006;371(1-2):66-70 Epub 2006 Mar.

Ingraham B.A, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008;24(1):139-149.

Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med. 2008;86(4):379-89 Epub 2007 De.

Johnson MA, Kimlin MG. Vitamin D, aging, and the 2005 Dietary Guidelines for Americans. Nutr Rev. 2006 Sep;64(9):410-21.

Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99(10):1044-1059.

Kawano K, Ogata N, Chiano M, Molloy H, Kleyn P, Spector TD, Uchida M, Hosoi T, Suzuki T, Orimo H, Inoue S, Nabeshima Y, Nakamura K, Kuro-o M, Kawaguchi H. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res. 2002;17(10):1744-1751.

KendrickJ, Targher G, Smits G, ChoncholM. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205(1):255-60 Epub 2008 No.

Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Association of low fetuin- A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003;361(9360):827-833.

Kiel DP, Kauppila LI, Cupples LA, Hannan MT, ODonnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int. 2001;68(5):271 -276.

Kimlin MG. Geographic location and vitamin D synthesis. Mol Aspects Med. 2008 Dec;29(6):453-61.

Kivineva M.; Blauer M.; Syvala H.; Tammela T.; Tuohimaa P. Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate. J.Steroid.Biochem.Mol.Biol. 1998 Aug; 66(3). P.121-127.

Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D. Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.J Steroid Biochem Mol Biol. 2007 Jan 15. (PubMed abstract).

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45-51.

Kuro-o M. Klotho. Pflugers Arch. 2010;459(2):333-343.

Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, GurnaniP, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science. 2005;309(5742):1829-33 Epub 2005 A.

Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial Am J Clin Nutr. 2007;85(6):1586-1591.

Leli C, Pasqualini L, Vaudo G, Gaggioli S, ScarponiAM, Mannarino E. Carotid intima-media thickness and bone turnover: the role of C-terminal telopeptide of type I collagen. Intern Emerg Med. 2010;5(2):127-34 Epub 2010 Fe.

Levy Y.; Knutson J.C.; Bishop C.; Shany S. The novel analog 1,24(S)- dihydroxyvitamin D2 is as equipotentas 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines. Anticancer.Res. 1998 May-Jun; 18(3A). P.1769-1775.

Losel, R., and Wehling, M. 2003. Nature Revs Mol. Cell Biol., 4, 46-55.

Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386(6620):78-81.

Maehr H, Uskokovic M, Adorini L, Penna G, Mariani R, Panina P, Passini N, Bono E, Perego S, Biffi M, Holick M, Spina C, Suh N. Calcitriol derivatives with two different side chains at C-20III. J. Steroid. Biochem Mol. Biol. 2007 Jan 23.

Marcus R., Wong M., Heath H., III and Stock J.L. Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint. Endocrine Reviews 2002. 23.(1):16-37.

Martin S. New agents in clinical oncology. //IDrugs. 2007 Feb;10(2): 99-101.

Mattila KJ. Dental infections as a risk factor for acute myocardial infarction. Eur Heart J. 1993 Dec;14 Suppl K:51-3.

Mertens PR, Muller R. Vitamin D and cardiovascular risk. Int Urol Nephrol. 2010;42(1):165-71 Epub 2009 De.

Miller G.J. Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer Metastasis Rev. 1998-99; 17(4). P.353-360.

Moats C, Rimm EB. Vitamin intake and risk of coronary disease: observation versus intervention. Curr Atheroscler Rep. 2007;9(6):508-514.

Moon J, Bandy B, Davison AJ. Hypothesis: etiology of atherosclerosis and osteoporosis: are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr. 1992;11(5):567-583.

Nagpal, S, Songqing N, and Radhakrishnan, R (2005) Noncalcemic Actions of Vitamin D Receptor Ligands Full Text Endocrine Reviews 26 (5): 662-687.

Nayler WG. Calcium, calcium antagonism, atherosclerosis, and ischemia. J Cardiovasc Pharmacol. 1992;19 Suppl 2:S17-S21.

Neuprez A, Bruyere O, Collette J, Reginster JY. Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health. 2007 Apr 26;7:64.

Ods WJ, McKinley AR, Moore MR, Kimlin MG. In vitro model of vitamin D3 (cholecalciferol) synthesis by UV radiation: dose-response relationships. J Photochem Photobiol B. 2008 Nov 13;93(2):88-93.

Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 1990;143(3):420-430.

Owens DS, Katz R, Takasu J, Kronmal R, Budoff MJ, OBrien KD. Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA). Am J Cardiol. 2010;105(5):701-708.

Pelczynska M, Switalska M, Maciejewska M, Jaroszewicz I, Kutner A, Opolski A. Antiproliferative activity of vitamin D compounds in combination with cytostatics. Anticancer Res. 2006 Jul-Aug;26(4A):2701-5. (PubMed abstract).

Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem. 1999;274(32):22739-227 46.

Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, Castellano G, Gesualdo L, Ktena M, Schena FP, Grandaliano G. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis. 2009;53(3):467-74 Epub 2009 Ja.

Pessana F, Armentano R, Chironi G, Megnien JL, Mousseaux E, Simon A. Subclinical atherosclerosis modeling: Integration of coronary artery calcium score to Framingham equation. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5348-5351.

Phair RD. Cellular calcium and atherosclerosis: a brief review. Cell Calcium. 1988;9(5-6):275-284.

Plank MJ, Wall DJ, David T. Atherosclerosis and calcium signalling in endothelial cells. Prog Biophys Mol Biol. 2006;91(3):287-313 Epub 2005 S.

Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.Seasonal and geographical variations in lung cancer prognosis in Norway Does Vitamin D from the sun play a role? Lung Cancer. 2007 Jan 4. (PubMed abstract).

Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology (Carlton). 2006;11(5):455-461.

Reis Jp, von Muhlen D, Michos ED, Miller ER 3rd, Appel LJ, Araneta MR, Barrett-Connor E. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009;207(2):585-90 Epub 2009 Ju.

Richy F, Dukas L, Schacht E. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif Tissue Int. 2008 Feb;82(2):102-7.

Rosen BD, Fernandes V, McClelland RL, Carr JJ, Detrano R, Bluemke DA, Lima JA. Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis). JACC Cardiovasc Imaging. 2009;2(10):1175-1183.

Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89(9):4246-4253.

Schwartz G.G.; Wang M.H.; Zang M.; Singh R.K.; Siega G.P. 1 alpha,25-Di hydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomarkers Prev. 1997 Sep; 6(9). P.727-732.

Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol. 2005;63(2):146-157.

Shi Q, Gross KW, Sigmund CD. Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem. 2001;276(5):3597-603 Epub 2000.

Simon A, Levenson J. Effects of calcium channel blockers on atherosclerosis: new insights. Acta Cardiol. 2002;57(4):249-255.

Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax. 2007Nov;62(11):1003-7.

Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1688-1695.

Skogsberg J, McMahon AD, Karpe F, Hamsten A, Packard CJ, Ehrenborg E. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med. 2003;254(6):597-604.

Staal A, van Wijnen AJ, Birkenhager JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol. 1996;10(11):1444-1456.

Swami S, Krishnan AV, Moreno J, Bhattacharyya RB, Peehl DM, Feldman

D. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.J Nutr. 2007 Jan;137(1):205S- 10S. (PubMed abstract).

Tarcin O, Yavuz dG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94(10):4023-30 Epub 2009 J.

Thompson GR, Partridge J. Coronary calcification score: the coronary-risk impact factor. Lancet. 2004;363(9408):557-559.

Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer. 2007;43(11):1701-12.

Twombly R. Negative Womens Health Initiative findings stir consternation, debate among researchers. J Natl Cancer Inst. 2006;98(8):508-510.

Vrins CL, van der Velde AE, van den Oever K, Levels JH, Huet S, Oude Elferink RP, Kuipers F, Groen AK. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J Lipid Res. 2009;50(10):2046-54 Epub 2009 M.

Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, OSullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, et al Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684-69.

WakasugiM, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y, Onaya T. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. 1991;42(2):127-136.

Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. Large- scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005;19(11):2685-95 Epub 2005 J.

Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol. 2007;18(1):41 -46.

<< | >>
: . ., . .. - 61 . - .: , 2012- 747 .. 2012


- -
- - - - - - - - - - - - - -